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Abstract A sensitive electrogenerated chemiluminescence
(ECL) peptide-based biosensor was fabricated for the
determination of troponin I (TnI) by employing gold
nanoparticles as amplification platform. Two specific peptides
including peptide1 with a sequence of CFYSHSFHENWPS
and peptide2 with a sequence of FYSHSFHENWPSK were
employed as capture peptide and report peptide, respectively.
The peptide2 was labeled with ruthenium bis(2,2′-bipyridine)
(2,2′-bipyridine-4,4′-dicarboxylic acid)-N-hydroxysuccinimide
ester (Ru(bpy)2(dcbpy)NHS) at NH2-containing lysine via
acylation reaction and utilized as the ECL probe. Gold
nanoparticles were electrodeposited onto gold electrode and
used as an amplification platform. The peptide-based biosensor
was fabricated by self-assembling peptide1 onto the surface of
gold nanoparticles-modified gold electrode through a thiol-
containing cysteine at the end of the peptide1. When the
biosensor reacted with target TnI, and then incubated with the
ECL probe, a strong ECL response was electrochemically
generated. The ECL intensity is directly proportional to the
logarithm of the concentration of TnI in the range from 1 to
300 pg/mL. The biosensor employing gold nanoparticles as
amplification platform shows high sensitivity for the detection
of TnI with a detection limit of 0.4 pg/mL (S /N =3). Moreover,
the biosensor is successfully applied to analysis of TnI in
human serum sample. This work demonstrates that the
combination of a highly binding peptide with nanoparticle
amplification is a great promising approach for the design of
ECL biosensor.
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Introduction
Acute myocardial infarction is a major cause of human death
and responsible for one third of deaths in the world.
Measurement of cardiac markers is critical in assisting the
diagnosis of acute myocardial infarction [1, 2]. Cardiac
troponin I (TnI), with a molecular weight of 24 kDa, a part
of the troponin complex that is present in cardiac muscle
tissues, has been known as a reliable biomarker of cardiac
muscle tissue injury andwas widely used in the early diagnosis
of acute myocardial infarction [3, 4]. The concentration of TnI
in blood rises rapidly within 4–6 h after the onset of an acute
myocardial infarction and reaches to the maximum at
approximately 12 h. After 6–8 days, the TnI level returns to
normal, and thus, the concentration of TnI in blood can provide
a long diagnostic window for detecting cardiac injury [3]. A
variety of methods such as colorimetric [5], electrochemical [2,
3], fluorescent [6, 7], and chemiluminescence [8] methods
have been developed to determine TnI. Despite the extensive
development of these methods, the major limitation in
currently used methods for the determination of TnI assays is
low sensitivity at the time of a patient's presentation, owing to a
delayed increase in circulating levels of cardiac troponin [2].
Therefore, it is still a critical demand on sensitive and specific
methods for the determination of TnI, especially in the point-
of-care applications.
Electrogenerated chemiluminescence (also called
electrochemiluminescence and abbreviated ECL) method
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has attracted considerable interest due to its high sensitivity,
rapidity, easy controllability, and wide dynamic range
[9, 10]. Several ECL methods have been developed for
the determination of TnI [11–15]. Cui designed ECL
immunosensor for the detection of human cardiac troponin I
by using luminol [11] andN-(aminobutyl)-N-(ethylisoluminol)
[12] -functionalized gold nanoparticles as labels. Smith
developed an ECL immunoassay for detection of rat TnI in
serum [13]. The commonly used ECL immunoassays are
normally conducted by employing antibodies as molecular
recognition elements. However, the antibody drawbacks
associated with the production and stability. Short linear
binding peptides, which are obtained using phage display, have
received considerable interest in protein analysis due to the
advantages, such as stable, resistant to harsh environments,
and more amenable to engineering at the molecular level than
antibodies [16]. Recently, Park et al. reported a new peptide
(FYSHSFHENWPS) that selectively bound to TnI with a
disassociation constant of the complex in nanomolar level
[17]. We developed two homogeneous ECL peptide-based
methods for the determination of TnI using this peptide as a
molecular recognition element [14, 15]. In previously work
[14], one peptide (FYSHSFHENWPSK), as a molecular
recognition element, was labeled with ruthenium complex
through NH2-containing lysine on the peptide via acylation
reaction and utilized as an ECL probe. In the presence of TnI,
a decrease in ECL signal was observed upon the binding
event between the ECL probe and target TnI. The binding
of small peptide with large target protein results in a sensitive
ECL detection of protein compared with homogeneous
immunoassay employing antibody as recognition element.
However, the detection limit of previously homogeneous
ECL method (1.2×10−10 g/mL) is limited due to the high
background and only one ECL molecule is attached directly
to each peptide.
The elaboration of ECL biosensors is probably one of the
most promising ways to solve some of the problems
concerning sensitivity, speediness, and stability. And much
effort has been devoted to improve the sensitivity of ECL
biosensors, such as employment of the nanoparticles-based
signal amplification strategy. Nanoparticles including carbon
nanotube, metal nanoparticles were employed as the
amplification platform for the immobilization of molecular
recognition elements [18], such as antibody [19], aptamer
[20], carbohydrate [21], or peptide[22]. Gold nanoparticles
(GNPs), with unique properties such as their fascinating
electrocatalytic activity, large surface area, excellent
conductivity, and stability, have beenwidely used in designing
ECL biosenesors [23, 24]. Generally, the ECL biosensors
utilize GNPs for the modification of the substrate electrodes,
which provide large electrode area and also facilitate the
electron transfer between the ECL signals and the electrodes,
thus affording the possibility of the improvement of ECL
performance. The unique properties of GNPs-modified
electrode interfaces lead to novel ECL biosensors with high
sensitivity and good stability in immunoassay [25], DNA
bioassay [26], and glycan biosensor [27]. In an alternative
way, GNPs can work as carriers of conventional ECL signals
such as luminol [11] and ruthenium complex [28] and,
thus, afford substantial ECL signal amplification. We
developed an ECL immunoassay for the determination
of human immunoglobulin G at gold nanoparticles-modified
paraffin-impregnated graphite electrode [29], an ECL DNA
biosensor at gold nanoparticles-modified gold electrode [30]
and a signal off aptasensor for the determination of thrombin
at gold nanoparticles-modified gold electrode [31] with high
sensitivity.
The aim of this work is to develop a highly sensitive ECL
peptide-based method for the determination of protein, on
basis of the idea of encompassing gold nanoparticles as
amplification platform and peptide as molecular recognition
element. The principle scheme is demonstrated in Fig. 1. Two
specific peptides including peptide1 with a sequence of
CFYSHSFHENWPS, in which a thiol-containing cysteine
residue was incorporated at the end of the specific peptide to
facilitate self-assembly onto the surface of gold, peptide2 with
a sequence of FYSHSFHENWPSK, in which a NH2-
containing lysine residue was incorporated at the end of the
peptide to covalently couple with ECL signal, were designed
according to ref. [17] and employed as capture peptide
and report peptide, respectively. The peptide2 was labeled with
ruthenium bis(2,2′-bipyridine) (2,2′-bipyridine-4,4′-dicarboxylic
acid)-N -hydroxysuccinimide ester (Ru(bpy)2(dcbpy)NHS)
via acylation reaction through NH2-containing lysine at the
end of the peptide to form the ECL probe Ru-peptide2. Gold
nanoparticles were electrodeposited onto gold electrode and
used as an amplification platform. The ECL peptide-based
biosensor was fabricated by self-assembling the peptide1 onto
a gold nanoparticles-modified gold electrode surface through
a thiol-containing cysteine at the end of the peptide1. When
the biosensor reacted with target TnI, and then incubated with
the ECL probe, a strong ECL response was electrochemically
generated. In this paper, the characteristics of the ECL probe
and the ECL peptide-based biosensor and the analytical
performance for TnI are presented.
Experimental
Reagents and apparatus
Two peptides chemically synthesized, including peptide1
with a sequence of CFYSHSFHENWPS (13 mer, MW=1,
640.77), peptide2 with a sequence of FYSHSFHENWPSK
(13 mer, MW=1,665.80), were designed according to ref.
[17] and purchased from Sinoasis Pharmaceuticals, Inc
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(China). Cardiac troponin I (TnI, human heart) was obtained
from Abcam, Inc. (Cambridge, UK). Mercaptohexanol
(MCH), Bis(2,2′-bipyridine)-4,4′-dicarboxybipyridine-
ruthenium di(N-succinimidyl ester) bis(hexafluorophosphate)
(Ru(bpy)2(dcbpy-NHS)(PF6)2, abbreviated as Ru) and
HAuCl4 were obtained from Sigma Aldrich (USA). Human
alpha-fetoprotein (AFP) and prostate specific antigen (PSA)
were obtained from Fitzgerald Industries International, Inc.
(USA). Human immunoglobulin G (IgG) and bovine serum
albumin (BSA) were obtained from Beijing Biosynthesis
Biotechnology Co., Ltd. (China). Albumin chicken egg
protein was obtained from Sino-American Biotechnology
Co., Ltd. (China).
The serum samples were provided by Xianyang Central
Hospital (China). Phosphate buffered saline (PBS) (0.1 M)
consisted of 0.1 M NaH2PO4, 0.1 M Na2HPO4, and 0.1 M
KCl (pH 7.4). The other reagents used in this work were of
analytical grade and directly used without additional
purification. Millipore Milli-Q water (18.2 MΩ cm) was used
to prepare all solutions.
ECL measurements were performed with a MPI-A ECL
detector (Xi'an Remax Electronics, China). A commercial
cylindroid glass cell was used as an ECL cell, which contained
a conventional three-electrode system that consisted of a gold
electrode (2.0 mm diameter) as the working electrode, a
platinum wire as the counter electrode, and an Ag/AgCl
(saturated KCl) as the reference electrode. ECL emissions
were detected with a photomultiplier tube (PMT) that was
biased at −900 V unless otherwise stated. Electrochemical
experiments were performed with a CHI 660 electrochemical
workstation (Chenhua Instruments Co., China).
Preparation of ECL probes
The ECL probe, Ru(bpy)2(dcbpy-NHS)(PF6)2 labeled
peptide2 (Ru-peptide2), were synthesized according to
literatures with some modifications [14, 15]. Briefly, 1 mg of
the peptide2 (0.0006 mol) was dissolved in 0.5 mL of 0.1 M
phosphate buffer (PB) consisted of 0.1MNaH2PO4 and 0.1M
Na2HPO4 (pH 7.4). Then, a 25 μL 0.02 M Ru(bpy)2(dcbpy-
NHS)(PF6)2 was added into 0.5 mL 10-diluted peptide2
solution under stirring, followed by an overnight incubation.
The Ru-peptide2 was purified by dialysis for 12 h at 4 °C
using MD34-2 Da molecular weight cutoff membrane with
0.1 M PBS (pH 7.4). The concentration of Ru-peptide2
solution was estimated to be 1.5×10−5 M, on the basis of
UV absorbance of Ru(bpy)2(dcbpy-NHS)(PF6)2 at 457 nm
[32, 33].
Fabrication of the ECL peptide-based biosensor
The biosensor was fabricated by two steps including an
electrochemical deposition step and an immobilization step.
The procedure for the deposition of gold nanoparticles onto
gold electrode was adapted from the ref. [34]. Prior to the
experiment, the gold electrode was polished with 0.3 μm
alumina slurry and then ultra-sonicated in water for 5 min.
The polished gold electrode was immersed in 0.1 M HClO4
containing 0.1 % HAuCl4, which was degassed with N2
stream for at least 20 min before the electrochemical
deposition. Gold nanoparticles were electrodeposited on the
gold electrode by holding a constant potential of +1.1 V (vs.
Ag/AgCl, sat. KCl) for 60 s and then a constant potential of
Fig. 1 Schematic representation
of the ECL peptide-based
biosensor for the determination
of TnI
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−0.1 V for 5 min in 0.1 M HClO4 containing 0.1 % HAuCl4
to form gold nanoparticles-modified gold electrode (GNPs/
Au electrode).
The peptide1 (CFYSHSFHENWPS) was immobilized
onto the surface of GNPs/Au electrode by dipping the
electrode into 11.3 μM peptide1 solution for 2 h at 4 °C
and rinsing with 10 mM PB (pH 7.4) to remove the
unbinding peptide1. The peptide-modified GNPs/Au
electrode was then immersed in 1 mM mercaptohexanol
solution for 30 min to block the uncovered surface of the
electrode. The resulting electrode (peptide1/GNPs/Au
electrode) was washed with water and used as the ECL
peptide-based biosensor.
ECL measurement
The ECL peptide-based biosensor fabricated was immersed
in 100 μL 10 mM PBS (pH 7.4) containing different
concentrations of TnI for 1 h at room temperature. Then,
the resulting ECL peptide-based biosensor was dipped into
100 μL of 1.5 μM ECL probe for 1 h at room temperature.
After each incubation, the biosensor was rinsed thoroughly
with 10 mM PBS (pH 7.4) to remove adsorption
components. The ECL measurement was performed at a
constant potential of +0.90 V in 2.0 mL of 0.10 M PBS
(pH 7.4) containing 50 mM tripropylamine (TPA). The
concentration of TnI was quantified by an increased ECL
intensity (ΔI =IS –I0), where IS was the ECL intensity of
ECL peptide-based biosensor reacted with TnI and I0 was the
blank ECL intensity of ECL peptide-based biosensor. All
experiments were carried out at room temperature.
Results and discussion
Characterization of the ECL probe
The ECL probe Ru-peptide2 synthesized was characterized
by UV–vis spectroscopy and ECL. Figure 2a shows
UV–vis spectra of the peptide2, Ru(bpy)2(dcbpy)NHS
and Ru-peptide2. The characteristic peaks of peptide2
appear at 263 nm (line a) and the characteristic peaks of
Ru(bpy)2(dcbpy)NHS appear at 201, 276, and 457 nm
(line b). The characteristic absorption peaks of Ru-peptide2
appear at 207, 276, and 457 nm (line c), corresponding to the
characteristic peaks of Ru(bpy)2(dcbpy)NHS at 450, 276,
207 nm and peptide at 263 nm, respectively. This indicates
that Ru(bpy)2(dcbpy)NHS is labeled to the peptide2.
Figure 2b shows ECL intensity–potential profiles of
Ru(bpy)2(dcbpy-NHS)(PF6)2 (line a) and Ru-peptide2
(line b) in 0.10 M PBS containing 50 mM TPA. From
Fig. 2b, it can be seen that both ECL peaks appear at near +
900 mV, which is similar with that (+900 mV) in ref. [35],
indicating that the ECL behavior of Ru-peptide2 is similar to
that of Ru(bpy)2(dcbpy)NHS and Ru(bpy)2(dcbpy)NHS is
attached to peptide2.
Feasibility of ECL peptide-based biosensor
for the determination of TnI
The fabrication process of the peptide-based biosensor was
characterized by cyclic voltammetry in the presence of the
ferri/ferrocyanide redox couple as redox probe (see Fig. S1 A
in supporting information). As expected, K3[Fe(CN)6]/
K4[Fe(CN)6] showed the reversible behavior on a bare gold
electrode and on a gold nanoparticles-modified electrode with
a peak-to-peak separation ΔEp of 76 mV (Fig. S1 A, line a–
b). After gold nanoparticles were electrodeposited onto gold
electrode, the peak current increased from 23.89 to 29.21 μA
(Fig. S1 A, line b), ascribing to the increase of electrode
surface area, which is confirmed by the CV results in 0.1 M
H2SO4 (Fig. S1 B). The immobilization of peptide1 on the
surface of gold nanoparticles-modified gold electrode led to a
significant increase in the peak-to-peak separation (ΔEp=
143 mV) (Fig. S1 A, line c) and decrease of peak current
(21.22 μA), indicating that peptide1 is self-assembled on the
Fig. 2 a UV–vis spectra of peptide (a), Ru(bpy)2(dcbpy-NHS)(PF6)2
(b) and Ru-peptide2 (c). b ECL intensity-potential profiles of 1.5×
10−7 M Ru(bpy)2(dcbpy-NHS)(PF6)2 (a) and 1.5×10
−7 M Ru-peptide2
(b) in 0.10 M PBS (pH 7.4) containing 50 mM TPA. Scan rate, 50 mV/s
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electrode. This is mainly attributed to the fact that the peptide1
modified on the surface of the electrode prohibits the mass
transfer of [Fe(CN)6]
3−/4− from the solution to the surface of
electrode. After reacted with TnI and Ru-peptide2, the peak-
to-peak separation further increased (ΔEp=196 mV) and the
peak current decreased to 17.22 μA (Fig. S1A, line d). This
indicates that the peptide is self-assembled onto the electrode
surface and the sandwich conjugates is formed onto the
surface electrode.
Figure 3a shows the ECL intensity vs potential profiles of
the ECL peptide-based biosensor reacted with 1.0×10−11 and
1.0×10−10 g/mLTnI, respectively. Compared line a and line b,
it can be seen that the ECL peptide-based biosensor shows a
low ECL signal (line a, 1,048) while the ECL peptide-based
biosensor reacted with 1.0×10−11 g/mLTnI displays a higher
ECL signal (line b, 4,955) in 0.10 M PBS (pH 7.4) containing
50 mM TPA. Compared line b with line c, it can be clearly
observed that the ECL peak intensity increases from 4,955 to
8,648 as the concentration of TnI is elevated from 1.0×10−11
to 1.0×10−10 g/mL. The results indicate that the ECL method
is feasible for the determination of TnI.
In order to illustrate the function of gold nanoparticles,
another kind of the peptide-based biosensor was fabricated
by self-assembling peptide1 onto bare gold electrode surface
through a thiol-containing cysteine at the end of the peptide1
and evaluated according to the protocol described in
experimental section. Figure 3b shows the ECL intensity-
potential profiles of the ECL peptide-based biosensor
employing gold electrode as platform for the determination
of TnI. The ECL peptide-based biosensor shows a low ECL
signal (line a, 697). The ECL intensity were 2,779 (line b) and
4,576 (line c) after reactingwith 1.0×10−11 and 1.0×10−10 g/mL
TnI, respectively. Comparing Fig. 3a, b, the ECL intensity at
the peptide1/GNPs/Au electrode was 1.5–1.9 times higher
than that obtained at a peptide1/Au electrodes at same
condition. The packing density of the peptide1 on the different
electrodes surface is estimated on basis of the electrode
surface area and the amount of peptide1. The amount of
peptide1 was related with the charge associated with the
electrode desorption reaction arising from the one-electron
reduction of peptide1 layer on gold surface according
Faraday law [36]. The peptide densities at the bare electrode
and gold nanoparticles-modified electrode were 3.58×10−10
and 11.2×10−10 molecules.cm−2, respectively, corresponding
the effective electrode area of 0.037 mm2 for bare gold
electrode and 0.05 mm2 for gold nanoparticles-modified gold
electrode (as seen in supporting information Figure S2). The
packing density of the peptide1 on gold nanoparticles-
modified electrode was 3.1-folds larger than that of the bare
gold electrode. In summer, gold nanoparticles not only
facilitate the electron transfer at the electrode interface and
catalyze the ECL process of ruthenium complex/TPA system
[25, 37], but also increase the interface area of the electrode to
capture more molecular recognition element for recognition of
targets, and then immobilize numerous signal-generating
molecules. The signal enhancement of the gold nanoparticles
for the ECL peptide-based biosensor designed is evident.
Optimization of conditions
The applied potential is an important parameter because it
decides the sensitivity of the ECL peptide-based biosensors.
The dependence of the ECL intensity of the ECL peptide-
based biosensor on applied potential was checked for 1.0×
10−10 g/mL TnI. Figure 4a shows that the ECL intensity
increases when the applied potential is raised from +0.8 to +
0.9 Vand reaches a maximum at +0.9 V. Therefore, the constant
potential of +0.9 V was chosen in following experiments.
Figure 4b shows the effect of binding time between the
peptide1 and TnI on the ECL intensity. The ECL intensity
sharply increases with increasing binding time from 20 to
60min and reaches a maximum at about 60min.When further
Fig. 3 ECL intensity-potential profiles of the ECL peptide-based
biosensor fabricated on GNPs-modified gold electrode (a) and the ECL
peptide-based biosensor fabricated on bare gold electrode (b) in 0.10 M
PBS (pH 7.4) containing 50 mM TPA at a constant potential of 0.90 V,
before (a) and after reaction with 1.0×10−11 g/mL TnI (b) and 1.0×
10−10 g/mLTnI (c), respectively
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increasing the binding time, the ECL intensity decreases
slightly. This is attributed to steric and electrostatic hindrance
arising from themore tightly packed TnI monolayer. Figure 4c
demonstrates the effect of the binding time between TnI and
the Ru-peptide2 on the ECL intensity. The results showed that
the ECL intensity sharply increased with increasing binding
time from 20 to 60 min, and then, reached a maximum at
60 min. Considering both of the binding time between
peptide1 and TnI with the binding time of Ru-peptide2 and
TnI, we chosen 60 min as binding time for both of incubation
process in following experiments.
Analytical performance of ECL peptide-based biosensor
The quantitative behavior of the ECL peptide-based biosensor
fabricated was assessed under the optimized conditions.
Figure 5 shows the ECL intensity vs time profiles of the
ECL peptide-based biosensors for the determination of TnI.
The ECL intensity increases with an increase of the
concentration of TnI. The increased ECL intensity has a linear
relationship with the logarithm of the concentration of TnI in
the range from 1.0×10−12 to 3.0×10−10 g/mL. The linear
regression equation is ΔI =3,303 lgC +40,305(unit of C is
in gram per milliliter) and the correlation coefficient was
0.9662. The relative standard derivation for 1.0×10−11 g/mL
TnI was 2.8 %. The detection limit (DL) is 0.4 pg/mL, which
is 300-fold lower than that obtained by homogenous ECL
method using Ru-labeled peptide [14] and 3-fold lower than
that obtained by homogenous ECL method using Ru-
Fig. 4 a Effect of applied potential on the ECL intensity; b effect of
binding time between peptide1 and 1.0×10−10 g/mL TnI on the ECL
intensity. c Effect of binding time between 1.0×10−10 g/mL TnI
and Ru-peptide2 on the ECL intensity. In 0.10 M PBS (pH 7.4)
containing 50 mM TPA
Fig. 5 ECL intensity vs time profiles for different concentrations of TnI
in 0.10 M PBS (pH=7.4) containing 50 mM TPA: a 1.0×10−12 g/mL, b
5.0×10−12 g/mL, c 1.0×10−11 g/mL,d 3.0×10−11 g/mL, e 5.0×10−11 g/mL,
f 1.0×10−10 g/mL, g 3.0×10−10 g/mL. Insert, calibration curve of TnI.
Experimental conditions, applied potential, 0.90 V; binding time, 60 min;
0.10 M PBS (pH 7.4) containing 50 mM TPA









1 5.09 4.85±0.70 −4.7
2 2.94 2.95±0.06 0.4
3 1.02 1.01±0.01 −1.0
a The CL results of TnI in serum samples from clinical reports provided
by Xianyang Central Hospital.
b Confidence interval
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encapsulated liposomes labeled peptide as the ECL probe in
our previous report [15]. The employment of gold
nanoparticles as amplification platform and peptide as
molecular recognition element to improve the sensitivity is
evident.
The evaluation of the selectivity of the ECL peptide-based
biosensor was performed by examining 1.0×10−10 g/mL
(8.3×10−11 M) TnI or 1.5×10−7 M other proteins including
AFP, PSA, albumin chicken egg protein and IgG, respectively.
A significant increase in ECL intensity (72.5 %) by the
interaction with TnI was observed (as shown in Fig. S3). On
the other hand, very slight increases in ECL intensity were
found for the other tested proteins including AFP (7.2 %),
PSA (6.3 %), albumin chicken egg protein (8.4 %), and IgG
(7.9 %), respectively. This indicates that the developed
strategy has good selectivity for TnI.
Sample analysis
To evaluate a potential application of the ECL peptide-based
biosensor, serum samples obtained from Xianyang Central
Hospital were assayed using the proposed method in this
work. The results are presented in Table 1. The obtained
results show an acceptable agreement with the data provided
by Xianyang Central Hospital (China) using a standard
chemiluminescence (CL) method with an Abbott
Immunoanalyzer (Abbott Axsym, i1000, USA), no statistical
significance (P value=0.9) is obtained between the result
using the ECL method in this work and that CL method,
therefore, signifying the feasibility of the ECL method in
clinical sample.
Conclusion
In this work, we fabricated a high sensitive electrogenerated
chemiluminescence peptide-based biosensor for the detection
of TnI. Great signal amplification was achieved with an
extremely low detection limit of 0.4 pg/mL attributed to the
combination of gold nanoparticles as amplification platform
and peptide as molecular recognition element. The strategy
presented in this study could be easily extended to the
detection of other biomarkers.
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